Sektorale Bewertungen Laboratorios Farmaceuticos Rovi, S.A. Wiener Boerse
Aktien
ROVI
ES0157261019
ROVI
Pharmazeutika
|
Schlusskurs
Wiener Boerse
10.09.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 57.40 EUR | -0.43% |
|
-2.79% | -9.32% |
| 23.07. | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 23.07. | Laboratorios Farmaceuticos Rovi, S.A. legt Ergebnisse für das Halbjahr bis zum 30. Juni 2026 vor | CI |
Hauptkonkurrenten
| KGV (Y) | Price to Book (Y) | PEG (Y) | EV / Umsatz (Y) | Marktkap. / EBITDA (Y) | Marktkap. / EBIT (Y) | Dividendenrendite (Y) | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 31.77x | 20.16x | 0.6x | 11.54x | 23.41x | 24.8x | 0.62% | 994 Mrd. | ||
| 29.54x | - | -1.6x | - | - | - | 2.02% | 640 Mrd. | ||
| 32.92x | -468.23x | 0.14x | 7.63x | 15.78x | 16.44x | 2.67% | 454 Mrd. | ||
| 18.71x | 6.85x | 1.27x | 4.57x | 11.31x | 12.54x | 2.91% | 337 Mrd. | ||
| 19.41x | 5.51x | -10.47x | 5.08x | 12.59x | 13.42x | 3.21% | 261 Mrd. | ||
| 20.34x | 4.55x | 1.07x | 4.19x | 11.96x | 12.58x | 2.11% | 246 Mrd. | ||
| 23.87x | 18.03x | 2.15x | 6.3x | 11.23x | 14.47x | 2.67% | 204 Mrd. | ||
| 12.3x | 5.22x | -5.06x | 4.48x | 9.37x | 10.92x | 4.08% | 190 Mrd. | ||
| -43.47x | 10.7x | 0.29x | 6.35x | 24.81x | 60.02x | 2.29% | 178 Mrd. | ||
| 17.48x | 1.8x | 1.05x | 3.3x | 8.45x | 9.61x | 6.21% | 158 Mrd. | ||
| 52.98x | 8.36x | -1.45x | 9.54x | 32.7x | 26.25x | -.--% | 131 Mrd. | ||
| 11.34x | 5.34x | 0.18x | 3.18x | 8.26x | 8.96x | 3.97% | 130 Mrd. | ||
| 11.67x | 1.19x | -6.05x | 2.08x | 6.74x | 7.46x | 5.81% | 102 Mrd. | ||
| 13.51x | 4.33x | -1.9x | 2.7x | 8x | 8.9x | 3.93% | 95.94 Mrd. | ||
| 20.88x | 4.71x | 1.25x | 6.96x | 13.2x | 13.85x | 2.12% | 68.8 Mrd. | ||
| 44.86x | 1.21x | 12.73x | 2.76x | 9.74x | 27.55x | 3.61% | 58.91 Mrd. | ||
| 21.78x | 1.68x | -0.14x | 1.69x | 7.97x | 13.69x | 0.33% | 54.92 Mrd. | ||
| 53.11x | 5.01x | -1.26x | 3.32x | 12.26x | 13.86x | -.--% | 43.22 Mrd. | ||
| 30.65x | 4.14x | 1.7x | 7.08x | 24x | 26.84x | 0.57% | 41.9 Mrd. | ||
| Durchschnitt | 22.30x | -19.97x | -0.29x | 5.15x | 13.99x | 17.90x | 2.59% | 231 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | 23.65x | -47.42x | -0.64x | 6.92x | 16.16x | 19.06x | 2.29% |
- Börse
- Aktien
- A0M0GQ Aktie
- ROVI Aktie
- Sektor Laboratorios Farmaceuticos Rovi, S.A.
- Sektorale Bewertungen
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
















